Omeros (OMER) EBITDA Margin Growth (1y) (2011 - 2021)
Omeros (OMER) EBITDA Margin Growth (1y) (2011 - 2021) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Omeros |
737.87 Mn |
602.55 Mn |
9.31 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2021 |
7,162.00 |
| Jun 30, 2021 |
14,687.00 |
| Mar 31, 2021 |
-4,327.00 |
| Dec 31, 2020 |
-26,312.00 |
| Sep 30, 2020 |
-9,215.00 |
| Jun 30, 2020 |
-19,205.00 |
| Mar 31, 2020 |
-1,156.00 |
| Dec 31, 2019 |
1,943.00 |
| Sep 30, 2019 |
80,146.00 |
| Jun 30, 2019 |
198,199.00 |
| Mar 31, 2019 |
178,079.00 |
| Dec 31, 2018 |
1,339.00 |
| Sep 30, 2018 |
-82,205.00 |
| Jun 30, 2018 |
-195,229.00 |
| Mar 31, 2018 |
-176,946.00 |
| Dec 31, 2017 |
3,184.00 |
| Sep 30, 2017 |
8,913.00 |
| Jun 30, 2017 |
4,235.00 |
| Mar 31, 2017 |
15,374.00 |
| Dec 31, 2016 |
14,489.00 |
